Table 2. Characteristics by the vital status among South Texas childhood cancer patients.
| Characteristics | Vital status (number, percentage) | P value | ||
|---|---|---|---|---|
| Dead (n = 1,338) | Alive (n = 4,527) | Total | ||
| Gender | 0.04 | |||
| Female | 574 (42.9) | 2,086 (46.08) | 2,660 | |
| Male | 764 (57.1) | 2,441 (53.92) | 3,205 | |
| Race/ethnicity | 0.0002 | |||
| Hispanic | 1,062 (79.37) | 3,354 (74.09) | 4,416 | |
| Non-Hispanic White | 225 (16.82) | 991 (21.89) | 1,216 | |
| Others | 51 (3.81) | 182 (4.02) | 233 | |
| Urban/rural residence | ||||
| Urban | 1,178 (88.04) | 4,008 (88.54) | 5,186 | 0.62 |
| Rural | 160 (11.96) | 519 (11.46) | 679 | |
| Insurance | <0.0001 | |||
| Yes | 481 (35.95) | 2,430 (53.68) | 2,911 | |
| No | 32 (2.39) | 118 (2.61) | 150 | |
| Unknown | 825 (61.66) | 1,979 (43.72) | 2,804 | |
| Diagnosis age (years)a | <0.0001 | |||
| <1 | 128 (9.57) | 319 (7.05) | 447 | |
| 1–4 | 259 (19.36) | 1,144 (25.27) | 1,403 | |
| 5–9 | 241 (18.01) | 889 (19.64) | 1,130 | |
| 10–14 | 285 (21.30) | 857 (18.93) | 1,142 | |
| 15–19 | 425 (31.76) | 1,318 (29.11) | 1,743 | |
| Current age groups (years)b | ||||
| <18 | 973 (73.94) | 1,858 (41.04) | 2,831 | <0.0001 |
| 18–<25 | 298 (22.64) | 1,358 (30.00) | 1,656 | |
| 25–<30 | 26 (1.98) | 630 (13.92) | 656 | |
| 30–<35 | 15 (1.14) | 411 (9.08) | 426 | |
| 35–<40 | 3 (0.23) | 231 (5.10) | 234 | |
| ≥40 | 1 (0.08) | 39 (0.86) | 40 | |
| Stagec | <0.0001 | |||
| Localized | 307 (23.82) | 1,433 (32.34) | 1,740 | |
| Regional extension | 96 (7.45) | 475 (10.72) | 571 | |
| Distant | 704 (54.62) | 1,922 (43.38) | 2,726 | |
| Unknown | 182 (14.12) | 601 (13.56) | 783 | |
| Treatment | 0.25 | |||
| Yes | 1,187 (90.4) | 4,050 (90.97) | 5235 | |
| No | 126 (9.6) | 382 (8.58) | 530 | |
| Surgery | <0.0001 | |||
| Yes | 929 (69.43) | 3,448 (76.18) | 4,377 | |
| No | 409 (30.57) | 1,078 (23.82) | 1487 | |
| Chemotherapy | <0.0001 | |||
| Yes | 945 (70.73) | 2,541 (56.28) | 3,486 | |
| No | 391 (29.27) | 1,974 (43.72) | 2,365 | |
| Radiation therapy | 0.03 | |||
| Yes | 104 (7.80) | 277 (6.14) | 381 | |
| No | 1,229 (92.20) | 4,238 (93.86) | 5,467 | |
a P>0.05 for diagnosis age < 1 year vs. ages at 10–14 years, diagnosis age <1 year vs. ages at 15–19 years, diagnosis ages at 10–14 years vs. ages at 15–19 years, and diagnosis age at 1–4 years vs. ages at 5–9 years; P<0.05 for other two group comparisons.
b P>0.05 for current age 25–<30 years vs. 30–<35 years, current age 25–<30 years vs. 35–<40 years, current age 25–<30 years vs. ≥40 years, current age 35–<35 years vs. ≥40 years, current age 35–<40 years vs. ≥40 years; P<0.05 for any other two group comparisons.
cP>0.05 for stage as “localized” vs. “regional extension”; P<0.05 for stage as “distant” vs. “localized” and “distant” vs. “regional extension”.